Dobriceanu, R.-C.; Meca, A.D.; Boboc, I.K.S.; Mititelu-Tartau, L.; Naidin, M.S.; Turcu-Stiolica, A.; Bogdan, M.
Pentraxin-3 as a Biomarker in Diabetes Mellitus: Insights into Inflammation, Vascular Complications, and Modulation by Antidiabetic Medications. Biomedicines 2025, 13, 891.
https://doi.org/10.3390/biomedicines13040891
AMA Style
Dobriceanu R-C, Meca AD, Boboc IKS, Mititelu-Tartau L, Naidin MS, Turcu-Stiolica A, Bogdan M.
Pentraxin-3 as a Biomarker in Diabetes Mellitus: Insights into Inflammation, Vascular Complications, and Modulation by Antidiabetic Medications. Biomedicines. 2025; 13(4):891.
https://doi.org/10.3390/biomedicines13040891
Chicago/Turabian Style
Dobriceanu, Roxana-Cristina, Andreea Daniela Meca, Ianis Kevyn Stefan Boboc, Liliana Mititelu-Tartau, Mihaela Simona Naidin, Adina Turcu-Stiolica, and Maria Bogdan.
2025. "Pentraxin-3 as a Biomarker in Diabetes Mellitus: Insights into Inflammation, Vascular Complications, and Modulation by Antidiabetic Medications" Biomedicines 13, no. 4: 891.
https://doi.org/10.3390/biomedicines13040891
APA Style
Dobriceanu, R.-C., Meca, A. D., Boboc, I. K. S., Mititelu-Tartau, L., Naidin, M. S., Turcu-Stiolica, A., & Bogdan, M.
(2025). Pentraxin-3 as a Biomarker in Diabetes Mellitus: Insights into Inflammation, Vascular Complications, and Modulation by Antidiabetic Medications. Biomedicines, 13(4), 891.
https://doi.org/10.3390/biomedicines13040891